Galmed Pharma Stock Price (NASDAQ:GLMD)

Add to My Stocks
$11.45 $0.06 (0.52%) GLMD stock closing price Aug 17, 2018 (Closing)
Prev Close* : $11.51
Market Cap:
Day Low: $11.34
52 Week Low: $3.61
Open: $11.55
Volume: -
Day High: $11.62
52 Week High: $27.06

Latest Stock Market News

Latest Articles

Galmed Pharma News - From Partners

GLMD Stockcharts

View GLMD PE ratio, PS ratio stocks charts and compare with peers.
GLMD Chart
Note: Compare Galmed Pharma stock price history with the index and industry peers.

Galmed Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Galmed Pharma Returns

(return on equity)

Galmed Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

GLMD Industry Peers

Company Price Change (%)
Fennec Pharma (FENC)9.730.21 (2.11%)
Ardelyx (ARDX)3.950.15 (3.66%)
Can-fite Biopharma (CANF)1.190.02 (1.71%)
Conatus Pharma (CNAT)3.960.01 (0.25%)
Enanta Pharma (ENTA)92.583.19 (3.57%)
Can-fite Biopharma (CANF)1.190.02 (1.71%)
Medicinova (MNOV)9.10.17 (1.9%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ACER THERAPEUTS (ACER)28.942.7 (10.29%)
Tesaro Inc (TSRO)28.781.56 (5.73%)
Endocyte (ECYT)17.940.88 (5.16%)
Recro Pharma (REPH)6.120.3 (5.15%)
Achaogen (AKAO)5.920.24 (4.23%)
MOLECULAR TEMPL (MTEM)5.20.21 (4.21%)
Enanta Pharma (ENTA)92.583.19 (3.57%)
Top gainers from Medical-Drugs industry
* As of Aug 18, 2018
CompanyPriceChange (%)
Adamis Pharma (ADMP)2.450.38 (13.45%)
CTI BioPharma (CTIC)1.830.07 (3.68%)
Aratana Therapeutics (PETX)5.070.18 (3.43%)
Tetraphase Pharmaceuticals (TTPH)2.850.1 (3.39%)
United Therapeutics (UTHR)125.613.85 (2.97%)
Rigel Pharma (RIGL)2.620.08 (2.96%)
TherapeuticsMD (TXMD)5.390.16 (2.88%)
Top losers from Medical-Drugs industry
* As of Aug 18, 2018

Galmed Pharmaceuticals Ltd Stock News - Partner Headlines

Galmed Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues1.08M----
Net Income-12.29M-16.95M-10.62M9.1M-17.48M
Total Operating Expense13.44M17.34M10.86M9.13M14.56M
View Galmed Pharma income statement
balance sheet20172016201520142013
Total Assets19.64M16.45M24.26M32.92M-
Total Liabilities3.84M5.37M2.71M1.51M2.11M
Shareholders Equity15.79M11.07M21.54M31.4M-
View Galmed Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-1.39M2.75M--0.74M1.21M
Net Cash from (used by) Operating Activities-12.06M-12.12M-8.47M-9.24M-2.52M
Increase (Decrease) in Prop Plant And Equipment-0.01M--0.15M-0.77M-
View Galmed Pharma cash flow statement

Galmed Pharma Stock Message Board

As of last trading day, Galmed Pharma stock price was $11.45. The total market value as denoted by $183.1M for Galmed Pharma, is the market value of the company's outstanding shares. Galmed Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Galmed Pharma is worth a lot, it will most likely be reflected in an inflated Galmed Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in Galmed Pharma stock quote data shows the number of shares traded. For Ex: 95,635 Galmed Pharma shares were traded as of last trading day, as seen from Galmed Pharma stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Galmed Pharma dividend per share was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking Galmed Pharma stock price history.